L2Be Pharma
ActiveFrom the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
L2Be Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €57,221 and a net result of €14,987. Equity remains stable across the filed financial years (±1.2% per year). Its solvency ranks better than 39% of 4,331 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Register details
Who it is
KBO recordName
L2Be Pharma in French
Enterprise number
0764.501.936
Legal form
Private limited company
Status
Active, normale toestand
Founded
02-03-2021
Type
Legal entity
Where it is based
Registered office
Rue Saint-Paul(BIN) 47, 7130 Binche, Belgium
Establishments
1 establishment unit since 2021
What it does
NACEBEL 202574999
Other professional, scientific and technical activities main activity
70200
Business and other management consultancy
72101
Research and development on biotechnology
85592
Vocational training
Invoicing and payment
VAT number
BE 0764.501.936
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Registered office and establishments
1 establishment unit
L2Be Pharma
since 2021unit no. 2.314.045.163
Buildings and parcels at the address
Ground area
285 m²
Building footprint
85 m²
Building volume
1,014 m³
Parcel 56011C0042/00G002, Wallonia · tallest building 13.7 m.
1 parcel
Wallonia
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 56011C0042/00G002 | Wallonia | 285 m² | 1 · 85 m² | 13.7 m · 4 |